Industry
Medical - Pharmaceuticals
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Loading...
Open
0.60
Mkt cap
52M
Volume
59K
High
0.63
P/E Ratio
-1.39
52-wk high
2.25
Low
0.59
Div yield
N/A
52-wk low
0.55
Portfolio Pulse from Benzinga Newsdesk
October 10, 2024 | 10:29 am
Portfolio Pulse from Benzinga Newsdesk
October 02, 2024 | 11:59 am
Portfolio Pulse from Nabaparna Bhattacharya
September 13, 2024 | 11:37 am
Portfolio Pulse from Benzinga Newsdesk
August 29, 2024 | 6:14 am
Portfolio Pulse from Benzinga Newsdesk
June 11, 2024 | 8:24 am
Portfolio Pulse from Benzinga Newsdesk
May 23, 2024 | 9:32 am
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 5:02 pm
Portfolio Pulse from Benzinga Insights
March 21, 2024 | 10:15 am
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 8:49 am
Portfolio Pulse from Charles Gross
February 27, 2024 | 12:08 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.